#amicus therapeutics advancing

About Us Redefining Expectations in Rare Diseases Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined con

Hiroki, Age 26 The Wisdom to Focus on What is Good in the Present Moment While Hiroki’s disease may be limiting, his mind is vast and expansive. He is taking nothing for granted. The flowering bushes and cherry blossom trees on the Nagoya University

Kody, Age 43 Wishing for Healing From the Bottom of His Soul “I want this disease to be spoken about in the past tense. That’s what I want for everybody else—for this disease to be a distant memory.” Kody sits up straight against the raised back of h

Lisa, Age 57 Waiting Decades for a Diagnosis “When you go for decades with doctors telling you there is nothing wrong, you think it’s normal—you learn to live with it.” On a misty May morning, Lisa heads out to the backyard to make sure her hostas ha

Our Medicines We’re incredibly proud to have brought forward two treatments for rare diseases for patients in our first two decades, and we’re fully committed to do more.  The information below is intended for use in the United States.   For more inf